Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks

BACKGROUND: The Uganda ministry of Health recommends frequent blood glucose monitoring for the first six months on dolutegravir, in people with HIV (PWH) having pre-diabetes mellitus (pre-DM). We sought to determine if indeed PWH with pre-diabetes started on dolutegravir had worse blood glucose outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulindwa, Frank, Schwarz, Jean-Marc, Brusselaers, Nele, Nabwana, Martin, Bollinger, Robert, Buzibye, Allan, Amutuhaire, Willington, Yendewa, George, Laker, Eva, Kiguba, Ronald, Castelnuovo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418540/
https://www.ncbi.nlm.nih.gov/pubmed/37577475
http://dx.doi.org/10.21203/rs.3.rs-3154716/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418540/
https://www.ncbi.nlm.nih.gov/pubmed/37577475
http://dx.doi.org/10.21203/rs.3.rs-3154716/v1

Ejemplares similares